Rachel Gioscia-Ryan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antioxidants | 5 | 2020 | 1673 | 0.780 |
Why?
|
| Endothelium, Vascular | 11 | 2022 | 4428 | 0.740 |
Why?
|
| Oxidative Stress | 11 | 2021 | 3138 | 0.730 |
Why?
|
| Mitochondria | 7 | 2023 | 3683 | 0.700 |
Why?
|
| Aging | 14 | 2024 | 8765 | 0.650 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 363 | 0.570 |
Why?
|
| Aorta | 3 | 2021 | 2046 | 0.540 |
Why?
|
| Methylamines | 5 | 2022 | 136 | 0.460 |
Why?
|
| Vasodilation | 7 | 2022 | 967 | 0.420 |
Why?
|
| Organophosphorus Compounds | 1 | 2014 | 211 | 0.420 |
Why?
|
| Ubiquinone | 1 | 2014 | 183 | 0.410 |
Why?
|
| Vascular Diseases | 5 | 2022 | 1162 | 0.380 |
Why?
|
| Motor Activity | 5 | 2024 | 2722 | 0.370 |
Why?
|
| Superoxides | 5 | 2022 | 389 | 0.350 |
Why?
|
| Spermidine | 2 | 2024 | 63 | 0.330 |
Why?
|
| Sodium Nitrite | 2 | 2021 | 16 | 0.310 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 1112 | 0.290 |
Why?
|
| Arteries | 3 | 2020 | 1126 | 0.280 |
Why?
|
| Ferritins | 2 | 2020 | 600 | 0.270 |
Why?
|
| Lyases | 1 | 2022 | 42 | 0.210 |
Why?
|
| Reactive Oxygen Species | 4 | 2020 | 2149 | 0.210 |
Why?
|
| Mice | 16 | 2024 | 82074 | 0.170 |
Why?
|
| Brachial Artery | 2 | 2020 | 373 | 0.170 |
Why?
|
| Physical Endurance | 1 | 2022 | 370 | 0.170 |
Why?
|
| Carotid Arteries | 3 | 2020 | 943 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 22381 | 0.150 |
Why?
|
| Animals | 21 | 2024 | 169408 | 0.150 |
Why?
|
| Cardiovascular System | 1 | 2023 | 840 | 0.130 |
Why?
|
| Elastin | 1 | 2017 | 299 | 0.130 |
Why?
|
| Interleukin-1 | 1 | 2019 | 1251 | 0.130 |
Why?
|
| Informed Consent | 1 | 2022 | 1010 | 0.130 |
Why?
|
| Insulin Resistance | 2 | 2020 | 3982 | 0.120 |
Why?
|
| Iron | 2 | 2021 | 1813 | 0.120 |
Why?
|
| Inflammation | 4 | 2021 | 10869 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2020 | 1110 | 0.120 |
Why?
|
| Athletes | 1 | 2022 | 1162 | 0.120 |
Why?
|
| Obesity | 4 | 2021 | 13087 | 0.120 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 846 | 0.120 |
Why?
|
| Nitric Oxide | 3 | 2022 | 2149 | 0.110 |
Why?
|
| Muscle, Skeletal | 5 | 2024 | 4980 | 0.110 |
Why?
|
| Dietary Supplements | 5 | 2021 | 3442 | 0.110 |
Why?
|
| Animal Feed | 1 | 2013 | 105 | 0.100 |
Why?
|
| Hindlimb | 1 | 2014 | 516 | 0.100 |
Why?
|
| Locomotion | 1 | 2014 | 390 | 0.090 |
Why?
|
| Physical Exertion | 1 | 2014 | 668 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2014 | 911 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 980 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1812 | 0.090 |
Why?
|
| Postural Balance | 1 | 2014 | 639 | 0.080 |
Why?
|
| Acetylcholine | 2 | 2022 | 629 | 0.080 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 15662 | 0.070 |
Why?
|
| Glucose | 1 | 2019 | 4352 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2021 | 8541 | 0.070 |
Why?
|
| Exercise | 2 | 2021 | 5953 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3591 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1879 | 0.060 |
Why?
|
| Insulin | 1 | 2020 | 6610 | 0.060 |
Why?
|
| Cytokines | 2 | 2017 | 7453 | 0.060 |
Why?
|
| Autophagy | 1 | 2013 | 1351 | 0.060 |
Why?
|
| Male | 15 | 2024 | 365249 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 18454 | 0.060 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 1315 | 0.060 |
Why?
|
| Butanols | 1 | 2022 | 19 | 0.050 |
Why?
|
| Tyrosine | 2 | 2020 | 1427 | 0.050 |
Why?
|
| Consent Forms | 1 | 2022 | 55 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 72 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7472 | 0.040 |
Why?
|
| Humans | 18 | 2023 | 768887 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 339 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 871 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 263 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 706 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2020 | 658 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2022 | 1165 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2021 | 965 | 0.030 |
Why?
|
| Diet | 1 | 2013 | 8090 | 0.030 |
Why?
|
| Nitrites | 1 | 2014 | 156 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2123 | 0.030 |
Why?
|
| Nitrates | 1 | 2014 | 260 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 60110 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2013 | 186 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 2108 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2020 | 13054 | 0.020 |
Why?
|
| Adult | 6 | 2021 | 223818 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1675 | 0.020 |
Why?
|
| Female | 8 | 2021 | 397464 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2014 | 409 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2014 | 641 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1339 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 11879 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 171790 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3858 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 8055 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 223740 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 1627 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12469 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 65485 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2014 | 2990 | 0.010 |
Why?
|
| Cognition | 1 | 2020 | 7080 | 0.010 |
Why?
|
| Life Style | 1 | 2014 | 3931 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 89247 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4628 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23847 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39394 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11934 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18366 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23652 | 0.010 |
Why?
|